$Unicycive Therapeutics(UNCY.US)$This big drop is partially due to a reverse stock split that is coming soon. The stock price has closed below $1.00 since May 23rd. Despite the good news on the drug trials, Unicycive will need to raise the stock price in order to remain listed on the NasdaqCM…and this means a reverse stock split. Investors on trading platforms like Morgan Stanley, E*Trade, and TD Ameritrade are probably dumping their shares to avoid a $38.00 reorgani...
Unicycive Therapeutics股票讨论区
Unicycive Therapeutics 获美国专利商标局 (USPTO) 授予用于治疗急性肾损伤的 UNI-494 专利
Unicycive Therapeutics(纳斯达克股票代码:UNCY)已获得美国专利商标局授予 UNI-494 的美国专利号12,036,211号专利,确保在2040年之前保护知识产权。该专利涵盖了一种使用 UNI-494 化合物、一种新型烟酰胺酯衍生物和选择性药物治疗急性肾损伤或造影剂诱发的肾病的方法。
Unicycive Therapeutics, Inc.(纳斯达克代码:UNCY)是一家致力于为肾脏疾病患者开发疗法的临床阶段生物技术公司,最近公布了在关键临床期间进行的一项患者报告的结果调查的令人鼓舞的初步结果...
暂无评论